Global /South Korea /Healthcare /Drug Manufacturers - General /016580

Whan In Pharm Co.,Ltd.

016580

• KRX: 016580 • Delayed

11,840KRW 0.5%

7.76 USD

As of 13 June 2026, Whan In Pharm Co.,Ltd. has a market cap of $143.17M USD, ranking #23167 globally and #1003 in South Korea. It ranks #2087 in the Healthcare sector, and #751 in the Drug Manufacturers - General industry.

Global Rank

23167

Country Rank

1003

Sector Rank

2087

Industry Rank

751

Key Stats

Market Cap

$143.17MUSD

217.74B KRW

Enterprise Value

$101.36MUSD

154.7B KRW

Revenue (TTM)

$167.81MUSD

255.21B KRW

EBITDA (TTM)

$14.99MUSD

22.88B KRW

Net Income (TTM)

$8.94MUSD

13.6B KRW

EBITDA Margin

Profit Margin

5.3%

PE Ratio

13.7

Forward PE

11.9

PS Ratio

0.9

PB Ratio

0.5

EV/EBITDA

6.8

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Wonbum Lee open_in_new

Employees

623

Founded

1978

Website

whanin.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.5%	10%	12%	9.5%	2.1%	3.7%	0.3%	-27%	-44%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	016580 환인제약(주) ISIN: KR7016580003 Shares Out.: Shares Outstanding: 18.484M¹ Shares Float: 10.869M² TV: TradingView: KRX: 016580 SA: Stock Analysis: KRX: 016580 YF: Yahoo Finance: 016580.KS GF: Google Finance: KRX: 016580 BA: Barron's: 016580 MS: Morningstar: XKRX: 016580	11,840 KRW	TV: TradingView: KRX: 016580 SA: Stock Analysis: KRX: 016580 YF: Yahoo Finance: 016580.KS GF: Google Finance: KRX: 016580 BA: Barron's: 016580 MS: Morningstar: XKRX: 016580

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Whan In Pharm Co.,Ltd.

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitamin, external preparation, medical device, and sedative, hypnotic, and autonomic nervous system medications. The company was founded in 1978 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 6K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 5K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 4K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 3K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 3K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 3K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 532K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 382K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 252K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 224K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 202K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 192K%	20.5	Switzerland

chevron_leftBack